Smith & Nephew merger talks with J&J orthopaedics unit collapse over CEO role, FT reports
4 Articles
4 Articles
Smith & Nephew merger talks with J&J orthopaedics unit collapse over CEO role, FT reports
Oct 23 (Reuters) - Smith & Nephew's talks with Johnson & Johnson to combine with the US group’s orthopaedics division fell apart after the London-listed group refused to agree to its former CEO leading the merged business, the Financial Times reporte...
Johnson & Johnson and Smith & Nephew Merger: $10 Billion Debt and "Who Would Be CEO" Dispute
A proposed $34 billion merger between Johnson & Johnson’s orthopaedics business and Smith & Nephew would have involved approximately $10 billion in debt financing from the British medical-device maker while giving J&J shareholders 50.1% of the combined company, according to the Financial Times. The financing component was more than three times Smith & Nephew’s $3.02 billion in net debt as of June 27, 2026. Under the terms described by the outlet…
An unexpected crisis has occurred in merger talks expected to have repercussions in the global medical technology and healthcare sector. Although the parties had reached an agreement on the main financial terms and the structure of the deal...
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
